ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Toyama Chemical's Avigan showing promise against disease

A researcher at Toyama Chemical conducts experiments with test agents.

TOKYO -- More than 5,000 people around the world have died in the latest outbreak of Ebola, with many more expected to succumb to the disease.

     The antiviral drug Avigan, which was developed by midsize Japanese pharmaceutical company Toyama Chemical, may become an effective treatment for the deadly disease. 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more